Latest News & Features
Refine Search
Big Pharma
The UK government has announced a deal between the life sciences sector and the government, aimed at ensuring that the “next wave of breakthrough treatments” and innovative medical research and technologies are created in the country. 11 December 2017
Biotechnology
The English High Court has sided with Eli Lilly in holding that its UK-related claims in a patent case can be heard together with its European-based arguments in the UK. 8 December 2017
Americas
Non-profit group the Initiative for Medicines, Access & Knowledge (I-MAK) has brought another two patent challenges against Gilead over its hepatitis C medicine sofosbuvir. 8 December 2017
Big Pharma
An advocate general has said that regulatory authorities in “concerned” EU member states handling drug marketing authorisations are co-responsible for approved documents on data exclusivity. 7 December 2017
Americas
An IBM counsel has discussed how companies can harness their IP and gave an overview of the impact of artificial intelligence on healthcare. 7 December 2017
Big Pharma
An end of procedure notice issued by a reference EU member state before the expiry of a basic patent may not be treated as equivalent to a marketing authorisation. 7 December 2017
Europe
Brexit and second medical use patent claims were two topics featured in the roundtable discussions at Life Sciences Patent Network Europe, a conference held in London. 7 December 2017
Biotechnology
Attendees at yesterday’s Life Sciences Patent Network Europe conference learned exactly what in-house counsel want when it comes to private practice lawyers. 7 December 2017
Asia-Pacific
Basilea Pharmaceutica and Pfizer have reached a deal for a licence agreement for the antifungal medication Cresemba to cover China and 16 countries in the Asia-Pacific region. 7 December 2017
Americas
One of the key players in the CRISPR landscape initially had “no clue” about licensing the technology in the agricultural sector. 7 December 2017